Late-Differentiated Effector Neoantigen-Specific CD8+ T Cells Are Enriched in Peripheral Blood of Non-Small Cell Lung Carcinoma Patients Responding to Atezolizumab Treatment
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0695-9
Full Text
Open PDFAbstract
Available in full text
Date
September 12, 2019
Authors
Publisher
BMJ